Speaker Profile

Ph.D., CEO and Co-Founder, InterOme

Dr. Corina J Shtir holds a Ph.D. from the University of Southern California in Biostatistics with applications in Statistical Genetics and Epidemiology, a postdoctoral degree in neuroscience from the University of California Los Angeles, and a second postdoctoral degree in statistical genetics applied in diabetes at Cambridge, UK. Prior to her current role, Dr. Shtir was Global VP and Head of Precision Medicine at Thermo Fisher Scientific, where she led the growth of Thermo Fishers Precision Medicine segment into an operation encompassing more than 200 large or nationalscale programs, with a presence in 100+ countries. Dr. Shtir drives new business, strategy, and product development, expanding InterOmes global reach through multidisciplinary collaborations, joint ventures, and external partnerships.


Clinical & Research Tools Showcase:
InterOme Inc

InterOme is a digital health company that combines >30 years of experience in public health and precision medicine, custom software development, management services, and large-scale system integration. We solve general systemic problems through highly specialized approaches and deploy single-user applications up to enterprise-wide business systems.

Rapid Operationalization of Environmental & Biothreat Surveillance
InterOme provides digital and industry framework to assess and evaluate public health through integrative and automated operations.

 Session Abstract – PMWC 2023 Silicon Valley

Showcase Track S2 - January 25 2.45 P.M.-4.00 P.M.,Showcase Track S2 - January 26 1.30 P.M.-4.00 P.M.,Showcase Track S2 - January 27 1.15 P.M.-1.30 P.M.

The PMWC 2023 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.


Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by DEC. 7TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts

Contact Us:

Fields marked with an * are required 

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required